Please assess the completion status of the following clinical trial:

Trial Title: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Confirmed diagnosis of RA, axSpA, PsA or PsO~* No prior treatment with etanercept and eligibility for treatment with etanercept according to the summary of product characteristics.~Exclusion Criteria:~* The contraindications, special warnings, and precautions according to the summary of product characteristics for etanercept shall apply.~* The additional documentation of the patient in another post-marketing study with etanercept is not permitted.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Observation Group (Type: None): None

Based on this trial design, predict the completion outcome and termination type (if applicable).